Clinical Outcomes and 30-day Readmission Following Heart Failure Hospitalization in Patients Previously Treated For Obesity With GLP-1 Agonist Versus Bariatric Surgery

Authors

Nameer Ascandar, HCA HealthcareFollow
Bobby Malik, HCA HealthcareFollow
Waqas Qureshi
Aysu Erdemir, HCA HealthcareFollow
Eduardo J. Lazaro, HCA HealthcareFollow
Olu Oyesanmi, HCA HealthcareFollow
Sabry Omar
Robert J. Subbiondo, HCA HealthcareFollow
Michael Schandorf-Lartey, HCA HealthcareFollow

Files

Division

West Florida

Hospital

HCA Florida Sarasota Doctors Hospital

Specialty

Internal Medicine

Document Type

Poster

Publication Date

2025

Keywords

glucagon like peptide-1, GLP-1, heart failure, obesity, patient outcome

Disciplines

Cardiovascular Diseases | Internal Medicine | Medicine and Health Sciences | Quality Improvement

Original Publisher

HCA Healthcare Graduate Medical Education

Recommended Citation

Ascandar, Nameer; Malik, Bobby; Qureshi, Waqas; Erdemir, Aysu; Lazaro, Eduardo J.; Oyesanmi, Olu; Omar, Sabry; Subbiondo, Robert J.; and Schandorf-Lartey, Michael, "Clinical Outcomes and 30-day Readmission Following Heart Failure Hospitalization in Patients Previously Treated For Obesity With GLP-1 Agonist Versus Bariatric Surgery" (2025). West Florida Division GME Research Day 2025. 62.
https://scholarlycommons.hcahealthcare.com/westflorida2025/62